STOCK TITAN

Amaero (AMRO) S-1 Filings

AMRO NASDAQ

Here are the S-1 registration statements from Amaero Inc. (AMRO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An S-1 covers the registration statement a company files to sell shares publicly, so if you follow AMRO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMRO filings page.

Rhea-AI Summary

Amaero Inc. proposes an initial public offering of 3,883,496 shares of common stock; sales are expected to begin as soon as practicable after the registration statement becomes effective. Underwriters may buy up to 582,524 additional shares from Amaero. The assumed price is $5.15 per share, with the final price to be determined through negotiations. Estimated net proceeds are $15.7 million, or $18.5 million if the option is exercised in full. Amaero plans to use up to approximately $10.0 million for capital equipment over the next 12 months and the remainder for general corporate purposes, including working capital, operating expenses and research and development.

Amaero produces refractory and titanium alloy powders and PM-HIP components. Cash and cash equivalents were $13.589 million and total indebtedness was $19.6 million as of June 30, 2026. Preliminary, unaudited estimates for the three months ended September 30, 2026 put revenue at $3.960 million to $4.120 million and net loss attributable to stockholders at $9.070 million to $9.500 million, versus 2025 actual revenue of $3.050 million and loss of $4.096 million. Amaero identifies a material weakness in internal control and says substantial doubt about its ability to continue as a going concern will remain after the offering.

Rhea-AI Summary

Amaero Inc. is offering 7,456,500 shares of common stock in an initial public offering. Underwriters may purchase up to 1,118,475 additional shares. The preliminary assumed price is $7.06 per share, and Amaero estimates net proceeds of approximately $46.1 million, or approximately $53.4 million if the option is exercised in full. The proposed sale is to commence as soon as practicable after the registration statement becomes effective; the IPO price will be set through negotiations.

Amaero produces refractory and titanium alloy powders and near-net-shape components using powder metallurgy hot isostatic pressing. Its backlog was $15.3 million as of July 31, 2026. Amaero intends to use up to approximately $17.5 million of net proceeds for capital equipment over the next 12 months, with the remaining proceeds for general corporate purposes, including working capital, operating expenses and research and development.

For the six months ended June 30, 2026, revenue was $7.397 million versus $1.219 million in 2025, while loss from continuing operations was $13.433 million versus $8.901 million. Cash and cash equivalents were $13.589 million as of June 30, 2026. Amaero disclosed substantial doubt about its ability to continue as a going concern if the offering is not completed and identified a material weakness in internal control over financial reporting.

Rhea-AI Summary

Amaero Inc. (AMRO) is registering 7,456,500 shares of common stock in an initial public offering; the underwriters may buy up to an additional 1,118,475 shares from the company. The assumed initial public offering price is $7.06 per share, and Amaero estimates net proceeds of approximately $46.1 million, or approximately $53.4 million if the option is exercised in full. It intends to use up to approximately $17.5 million for capital equipment over the next 12 months, with remaining proceeds for general corporate purposes, including working capital, operating expenses and research and development. It may also use a portion for acquisitions or investments.

Amaero produces refractory and titanium alloy powders and PM-HIP components. Revenue for the six months ended June 30, 2026 was $7.397 million, versus $1.219 million in 2025. Loss from continuing operations was $13.433 million, versus $8.901 million. Backlog was $15.3 million as of July 31, 2026. Amaero identifies a material weakness in internal control over financial reporting and says substantial doubt exists about its ability to continue as a going concern if the offering is not completed.